Follow us for updates
© 2022
Read the Story →

Panfilo Lacson, Tito Sotto Test Negative for Cocaine, Drugs

After Duterte floated a 'cocaine user' among presidential aspirants.
by Arianne Merez
Nov 22, 2021
Photo/s: Vicente Tito Sotto's Facebook Page

Senators Panfilo Lacson, who is running for president, and his running mate, Senate President Vicente Sotto III, underwent voluntary drug testing on Monday after President Rodrigo Duterte alleged that one of those seeking to succeed him in 2022 was a cocaine user.

Both Lacson and Sotto tested negative for illegal drugs at the Philippine Drug Enforcement Agency, with Senate President Sotto emphasizing that they don't use cocaine.

Continue reading below ↓

"Dapat ang description - highest lider ng bansa, hindi high ang lider ng bansa," Lacson, who is running for president, said in a Facebook post.

ALSO READ: Lacson Plants Philippine Flag in Spratlys, Saying 'West Philippine Sea is Ours'

President Duterte alleged that the drug-using politician was involved with a group of rich individuals using cocaine in his hometown Davao City, and in Manila. His claims fueled speculations on social media with "Bongbong Narcos" trending on Twitter Philippines on Friday.

Bongbong Marcos, who is running for president alongside Duterte's daughter Sara Duterte-Carpio, had previously denied drug use. He also said during his vice presidential campaign in 2016 that he was willing to take a drug test.

Duterte's claims have also prompted the Philippine National Police to investigate the matter.

Continue reading below ↓
Recommended Videos

Reportr is now on Quento. Download the app or visit the Quento website for more articles and videos from Reportr and your favorite websites.

Latest Headlines
Read Next
Recent News
The news. So what? Subscribe to the newsletter that explains what the news means for you.
The email address you entered is invalid.
Thank you for signing up to On Three, reportr's weekly newsletter delivered to your mailbox three times a week. Only the latest, most useful and most insightful reads.
By signing up to newsletter, you agree to our Terms of Service and Privacy Policy.